Fundraising Fox

Nectome

YC W18

San Francisco, US · 5 employees · 2 known investors

Nectome provides cryogenic preservation of the human body and brain shortly after legal death, aiming to preserve neural structure in sufficient detail that future revival may become theoretically possible. The service targets individuals at end-of-life seeking experimental preservation as a potential pathway to future recovery.

BiotechDeep TechHealthtechLongevityNeurotechnologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W18)

ASAurelia Song
Aurelia SonginFounder/CEOAurelia Song is the founder and CEO of Nectome, a company developing preservation technology aimed at enabling future revival of terminally ill individuals.

Investors · 2

Company profile

researched Aug 2026

Nectome is a San Francisco-based company offering whole-body human preservation performed post-mortem, with the stated goal of enabling possible revival in the future. The company says it aims to preserve people within minutes after legal death so that both the body and the brain are maintained at a very high level of structural quality.

According to the company, that level of detail is intended to allow the connections between neurons and synapses to be traced throughout the brain. Nectome cites modern neuroscience for the proposition that a person's memory, skills and personality reside in this structure, and states its belief that the scientific and clinical literature supports the view that its preservation protocol can preserve an individual for hundreds of years in sufficient detail that revival is a theoretical possibility over the long term. The company draws an analogy to DNA preservation, which was feasible before genomes could be sequenced, arguing that verifiable preservation can precede the ability to interpret the underlying biology.

Business model

Nectome provides a preservation service performed after legal death, contracted directly with individuals; the website directs prospective customers to contact the company by email.

Full profile — technology, go-to-market, geography

Technology

A preservation protocol applied within minutes of legal death that is intended to preserve the body and brain at a level of detail sufficient to trace neuronal and synaptic connections and to maintain the tissue for hundreds of years.

Go-to-market

Direct inquiry through the company website, which invites prospective clients to email the company.

Individuals at the end of their lives, for whom the company positions preservation as a remaining experimental option that may permit recovery in the future.

Geography

Headquartered in San Francisco, United States.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Competitors · 1

by search overlap

Companies competing with Nectome for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Nectome do?
Nectome offers whole-body and brain preservation within minutes of legal death, aiming at possible future revival.
Who founded Nectome?
Nectome was founded by Aurelia Song.
Who are Nectome's investors?
Nectome's investors include Oyster Ventures, Y Combinator.
Where is Nectome headquartered?
Nectome is headquartered in San Francisco, US.